Showing results (741-750 of 3,524) with videos related to
Sort By:
Pageof 353
Thoracic Cancer|April 27, 2018
Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53Xinyan Wang, Jianwei ZhuThoracic Cancer|April 27, 2018
Image-based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10-year single institution experienceShaakir Hasan, Athanasios Colonias, Timothy Mickus, et al.Thoracic Cancer|July 21, 2018
Efficacy of pemetrexed and carboplatin with or without bevacizumab in lung adenocarcinoma patients with EGFR non-T790M mutations after progression on first-line EGFR-tyrosine kinase inhibitorsZhansheng Jiang, Yu Zhang, Yinli Yang, et al.Thoracic Cancer|July 27, 2018
Efficacy of combined icotinib and pemetrexed in EGFR mutant lung adenocarcinoma cell line xenograftsJiadong Cui, Yan Zhang, Di Su, et al.Thoracic Cancer|July 11, 2018
Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR-mutated non-small cell lung cancerYunkyoung Lee, Sojung Park, Woo Sung Kim, et al.Thoracic Cancer|July 31, 2018
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancerChunxin Lv, Xiuju Liu, Qiwen Zheng, et al.Thoracic Cancer|August 21, 2018
Amrubicin monotherapy for elderly patients with relapsed extensive-disease small-cell lung cancer: A retrospective studyHideyuki Sone, Satoshi Igawa, Masashi Kasajima, et al.Thoracic Cancer|August 21, 2018
Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapyZui Liu, Wei Ou, Ning Li, et al.Thoracic Cancer|August 23, 2018
Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variantPeng Song, Jingcheng Zhang, Congcong Shang, et al.Thoracic Cancer|September 14, 2018
Comparable immunoreactivity rates of PD-L1 in archival and recent specimens from non-small cell lung cancerYuki Nakamura, Tetsu Kobayashi, Yoichi Nishii, et al.Pageof 353